CAPLIN POINT LABORATORIES
Back to Income Statement
|
CAPLIN POINT LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹300 Cr | ₹242 Cr | ₹21,501 Cr | ₹177 Cr | ₹145 Cr |
What is the latest Consolidated Net Profit of CAPLIN POINT LABORATORIES ?
Year | Consolidated Net Profit |
---|---|
Mar2023 | ₹300 Cr |
Mar2022 | ₹242 Cr |
Mar2021 | ₹21,501 Cr |
Mar2020 | ₹177 Cr |
Mar2019 | ₹145 Cr |
How is Consolidated Net Profit of CAPLIN POINT LABORATORIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2023 | ₹300 Cr | 23.76 | |
Mar2022 | ₹242 Cr | -98.87 | |
Mar2021 | ₹21,501 Cr | 12,077.96 | |
Mar2020 | ₹177 Cr | 21.94 | |
Mar2019 | ₹145 Cr | - |
Compare Consolidated Net Profit of peers of CAPLIN POINT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CAPLIN POINT LABORATORIES | ₹9,884.8 Cr | -1% | -2.2% | 84% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,673.0 Cr | -2.9% | 0% | 59.6% | Stock Analytics | |
CIPLA | ₹119,930.0 Cr | 5.8% | 6.2% | 60.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹109,446.0 Cr | 5% | 8% | 25.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,261.0 Cr | -2.6% | 15.3% | 114.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,830.6 Cr | 0.9% | -1.5% | 32.2% | Stock Analytics |
CAPLIN POINT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CAPLIN POINT LABORATORIES | -1% |
-2.2% |
84% |
SENSEX | 2% |
2.3% |
22.2% |
You may also like the below Video Courses